nodes	percent_of_prediction	percent_of_DWPC	metapath
Ribavirin—NT5C2—neck—thyroid cancer	0.021	0.0939	CbGeAlD
Ribavirin—NT5C2—saliva-secreting gland—thyroid cancer	0.0164	0.0732	CbGeAlD
Ribavirin—SLC28A3—trachea—thyroid cancer	0.0152	0.0679	CbGeAlD
Ribavirin—ENPP1—thyroid gland—thyroid cancer	0.0137	0.0612	CbGeAlD
Ribavirin—IMPDH1—saliva-secreting gland—thyroid cancer	0.0133	0.0595	CbGeAlD
Ribavirin—NT5C2—trachea—thyroid cancer	0.0127	0.0565	CbGeAlD
Ribavirin—ENPP1—head—thyroid cancer	0.0122	0.0543	CbGeAlD
Ribavirin—ADK—saliva-secreting gland—thyroid cancer	0.0105	0.0469	CbGeAlD
Ribavirin—IMPDH1—trachea—thyroid cancer	0.0103	0.0459	CbGeAlD
Ribavirin—NT5C2—thyroid gland—thyroid cancer	0.01	0.0447	CbGeAlD
Ribavirin—NT5C2—head—thyroid cancer	0.00889	0.0396	CbGeAlD
Ribavirin—ENPP1—lymph node—thyroid cancer	0.00852	0.038	CbGeAlD
Ribavirin—IMPDH1—thyroid gland—thyroid cancer	0.00813	0.0363	CbGeAlD
Ribavirin—ADK—trachea—thyroid cancer	0.0081	0.0362	CbGeAlD
Ribavirin—IMPDH1—head—thyroid cancer	0.00721	0.0322	CbGeAlD
Ribavirin—SLC29A1—trachea—thyroid cancer	0.0069	0.0308	CbGeAlD
Ribavirin—ADK—thyroid gland—thyroid cancer	0.00641	0.0286	CbGeAlD
Ribavirin—NT5C2—lymph node—thyroid cancer	0.00622	0.0278	CbGeAlD
Ribavirin—ADK—head—thyroid cancer	0.00569	0.0254	CbGeAlD
Ribavirin—SLC29A1—thyroid gland—thyroid cancer	0.00546	0.0244	CbGeAlD
Ribavirin—IMPDH1—lymph node—thyroid cancer	0.00505	0.0225	CbGeAlD
Ribavirin—SLC29A1—head—thyroid cancer	0.00484	0.0216	CbGeAlD
Ribavirin—ADK—lymph node—thyroid cancer	0.00398	0.0178	CbGeAlD
Ribavirin—SLC29A1—lymph node—thyroid cancer	0.00339	0.0151	CbGeAlD
Ribavirin—ENPP1—Endochondral Ossification—PTCH1—thyroid cancer	0.00228	0.0878	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—SMUG1—thyroid cancer	0.0018	0.0694	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000662	0.0255	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000662	0.0255	CbGpPWpGaD
Ribavirin—ENPP1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—thyroid cancer	0.000656	0.0252	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TRIM24—thyroid cancer	0.000571	0.022	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—MINPP1—thyroid cancer	0.000562	0.0216	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—MINPP1—thyroid cancer	0.000562	0.0216	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CHST14—thyroid cancer	0.000537	0.0207	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TRIM33—thyroid cancer	0.000509	0.0196	CbGpPWpGaD
Ribavirin—SLC28A3—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.000496	0.0191	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—TPR—thyroid cancer	0.000494	0.019	CbGpPWpGaD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—CP—thyroid cancer	0.000494	0.019	CbGpPWpGaD
Ribavirin—SLC29A1—Fluoropyrimidine Activity—TP53—thyroid cancer	0.000479	0.0184	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—NDUFA13—thyroid cancer	0.000478	0.0184	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—NDUFA13—thyroid cancer	0.000478	0.0184	CbGpPWpGaD
Ribavirin—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.000472	0.000629	CcSEcCtD
Ribavirin—Nasopharyngitis—Epirubicin—thyroid cancer	0.000469	0.000625	CcSEcCtD
Ribavirin—Face oedema—Doxorubicin—thyroid cancer	0.000468	0.000624	CcSEcCtD
Ribavirin—Muscular weakness—Epirubicin—thyroid cancer	0.000462	0.000617	CcSEcCtD
Ribavirin—Cardiac arrest—Doxorubicin—thyroid cancer	0.000461	0.000615	CcSEcCtD
Ribavirin—Dizziness—Sorafenib—thyroid cancer	0.000461	0.000615	CcSEcCtD
Ribavirin—Mood swings—Doxorubicin—thyroid cancer	0.000459	0.000613	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—MINPP1—thyroid cancer	0.000458	0.0176	CbGpPWpGaD
Ribavirin—Abdominal distension—Epirubicin—thyroid cancer	0.000456	0.000608	CcSEcCtD
Ribavirin—Ataxia—Doxorubicin—thyroid cancer	0.000456	0.000608	CcSEcCtD
Ribavirin—Asthma—Epirubicin—thyroid cancer	0.000453	0.000604	CcSEcCtD
Ribavirin—Influenza—Epirubicin—thyroid cancer	0.000453	0.000604	CcSEcCtD
Ribavirin—Dehydration—Doxorubicin—thyroid cancer	0.000451	0.000601	CcSEcCtD
Ribavirin—NT5C2—Metabolism—CHST14—thyroid cancer	0.000449	0.0173	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—CHST14—thyroid cancer	0.000449	0.0173	CbGpPWpGaD
Ribavirin—Dry skin—Doxorubicin—thyroid cancer	0.000445	0.000593	CcSEcCtD
Ribavirin—Pancreatitis—Epirubicin—thyroid cancer	0.000444	0.000592	CcSEcCtD
Ribavirin—Vomiting—Sorafenib—thyroid cancer	0.000443	0.000591	CcSEcCtD
Ribavirin—Abdominal pain upper—Doxorubicin—thyroid cancer	0.000443	0.000591	CcSEcCtD
Ribavirin—Angina pectoris—Epirubicin—thyroid cancer	0.000441	0.000589	CcSEcCtD
Ribavirin—Rash—Sorafenib—thyroid cancer	0.00044	0.000586	CcSEcCtD
Ribavirin—Dermatitis—Sorafenib—thyroid cancer	0.000439	0.000586	CcSEcCtD
Ribavirin—Breast disorder—Doxorubicin—thyroid cancer	0.000438	0.000584	CcSEcCtD
Ribavirin—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.000437	0.000582	CcSEcCtD
Ribavirin—Headache—Sorafenib—thyroid cancer	0.000437	0.000582	CcSEcCtD
Ribavirin—Bronchitis—Epirubicin—thyroid cancer	0.000436	0.000581	CcSEcCtD
Ribavirin—Nasopharyngitis—Doxorubicin—thyroid cancer	0.000434	0.000578	CcSEcCtD
Ribavirin—Muscular weakness—Doxorubicin—thyroid cancer	0.000428	0.00057	CcSEcCtD
Ribavirin—ADK—Metabolism—MINPP1—thyroid cancer	0.000426	0.0164	CbGpPWpGaD
Ribavirin—Neutropenia—Epirubicin—thyroid cancer	0.000424	0.000565	CcSEcCtD
Ribavirin—Abdominal distension—Doxorubicin—thyroid cancer	0.000422	0.000563	CcSEcCtD
Ribavirin—ENPP1—Endochondral Ossification—AKT1—thyroid cancer	0.000421	0.0162	CbGpPWpGaD
Ribavirin—Upper respiratory tract infection—Epirubicin—thyroid cancer	0.000421	0.000561	CcSEcCtD
Ribavirin—Influenza—Doxorubicin—thyroid cancer	0.000419	0.000559	CcSEcCtD
Ribavirin—Asthma—Doxorubicin—thyroid cancer	0.000419	0.000559	CcSEcCtD
Ribavirin—Pollakiuria—Epirubicin—thyroid cancer	0.000419	0.000558	CcSEcCtD
Ribavirin—Nausea—Sorafenib—thyroid cancer	0.000414	0.000552	CcSEcCtD
Ribavirin—Photosensitivity reaction—Epirubicin—thyroid cancer	0.000414	0.000551	CcSEcCtD
Ribavirin—Weight increased—Epirubicin—thyroid cancer	0.000412	0.00055	CcSEcCtD
Ribavirin—Pancreatitis—Doxorubicin—thyroid cancer	0.000411	0.000548	CcSEcCtD
Ribavirin—Weight decreased—Epirubicin—thyroid cancer	0.00041	0.000547	CcSEcCtD
Ribavirin—Hyperglycaemia—Epirubicin—thyroid cancer	0.000409	0.000545	CcSEcCtD
Ribavirin—Angina pectoris—Doxorubicin—thyroid cancer	0.000408	0.000545	CcSEcCtD
Ribavirin—Pneumonia—Epirubicin—thyroid cancer	0.000406	0.000542	CcSEcCtD
Ribavirin—Infestation—Epirubicin—thyroid cancer	0.000404	0.000539	CcSEcCtD
Ribavirin—Infestation NOS—Epirubicin—thyroid cancer	0.000404	0.000539	CcSEcCtD
Ribavirin—Bronchitis—Doxorubicin—thyroid cancer	0.000403	0.000538	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Epirubicin—thyroid cancer	0.0004	0.000534	CcSEcCtD
Ribavirin—Renal failure—Epirubicin—thyroid cancer	0.000397	0.00053	CcSEcCtD
Ribavirin—Neuropathy peripheral—Epirubicin—thyroid cancer	0.000396	0.000528	CcSEcCtD
Ribavirin—Jaundice—Epirubicin—thyroid cancer	0.000394	0.000525	CcSEcCtD
Ribavirin—Stomatitis—Epirubicin—thyroid cancer	0.000394	0.000525	CcSEcCtD
Ribavirin—Urinary tract infection—Epirubicin—thyroid cancer	0.000393	0.000524	CcSEcCtD
Ribavirin—Conjunctivitis—Epirubicin—thyroid cancer	0.000393	0.000524	CcSEcCtD
Ribavirin—Neutropenia—Doxorubicin—thyroid cancer	0.000392	0.000523	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—NDUFA13—thyroid cancer	0.00039	0.015	CbGpPWpGaD
Ribavirin—Upper respiratory tract infection—Doxorubicin—thyroid cancer	0.00039	0.00052	CcSEcCtD
Ribavirin—Pollakiuria—Doxorubicin—thyroid cancer	0.000387	0.000516	CcSEcCtD
Ribavirin—Photosensitivity reaction—Doxorubicin—thyroid cancer	0.000383	0.00051	CcSEcCtD
Ribavirin—Hepatobiliary disease—Epirubicin—thyroid cancer	0.000382	0.000509	CcSEcCtD
Ribavirin—Weight increased—Doxorubicin—thyroid cancer	0.000381	0.000509	CcSEcCtD
Ribavirin—Epistaxis—Epirubicin—thyroid cancer	0.000381	0.000508	CcSEcCtD
Ribavirin—Weight decreased—Doxorubicin—thyroid cancer	0.000379	0.000506	CcSEcCtD
Ribavirin—Sinusitis—Epirubicin—thyroid cancer	0.000379	0.000505	CcSEcCtD
Ribavirin—Hyperglycaemia—Doxorubicin—thyroid cancer	0.000378	0.000504	CcSEcCtD
Ribavirin—Pneumonia—Doxorubicin—thyroid cancer	0.000376	0.000501	CcSEcCtD
Ribavirin—Infestation NOS—Doxorubicin—thyroid cancer	0.000374	0.000498	CcSEcCtD
Ribavirin—Infestation—Doxorubicin—thyroid cancer	0.000374	0.000498	CcSEcCtD
Ribavirin—Stevens-Johnson syndrome—Doxorubicin—thyroid cancer	0.000371	0.000494	CcSEcCtD
Ribavirin—SLC29A1—SLC-mediated transmembrane transport—SLC5A5—thyroid cancer	0.00037	0.0142	CbGpPWpGaD
Ribavirin—Bradycardia—Epirubicin—thyroid cancer	0.000369	0.000492	CcSEcCtD
Ribavirin—Renal failure—Doxorubicin—thyroid cancer	0.000367	0.00049	CcSEcCtD
Ribavirin—Neuropathy peripheral—Doxorubicin—thyroid cancer	0.000366	0.000489	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—CHST14—thyroid cancer	0.000366	0.0141	CbGpPWpGaD
Ribavirin—Haemoglobin—Epirubicin—thyroid cancer	0.000364	0.000486	CcSEcCtD
Ribavirin—Jaundice—Doxorubicin—thyroid cancer	0.000364	0.000486	CcSEcCtD
Ribavirin—Stomatitis—Doxorubicin—thyroid cancer	0.000364	0.000486	CcSEcCtD
Ribavirin—Rhinitis—Epirubicin—thyroid cancer	0.000364	0.000485	CcSEcCtD
Ribavirin—Conjunctivitis—Doxorubicin—thyroid cancer	0.000363	0.000484	CcSEcCtD
Ribavirin—Urinary tract infection—Doxorubicin—thyroid cancer	0.000363	0.000484	CcSEcCtD
Ribavirin—Haemorrhage—Epirubicin—thyroid cancer	0.000363	0.000484	CcSEcCtD
Ribavirin—Hepatitis—Epirubicin—thyroid cancer	0.000363	0.000484	CcSEcCtD
Ribavirin—ENPP1—Metabolism—HPGD—thyroid cancer	0.000362	0.0139	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—HPGD—thyroid cancer	0.000362	0.0139	CbGpPWpGaD
Ribavirin—ADK—Metabolism—NDUFA13—thyroid cancer	0.000362	0.0139	CbGpPWpGaD
Ribavirin—Hypoaesthesia—Epirubicin—thyroid cancer	0.000361	0.000481	CcSEcCtD
Ribavirin—Pharyngitis—Epirubicin—thyroid cancer	0.00036	0.00048	CcSEcCtD
Ribavirin—Urinary tract disorder—Epirubicin—thyroid cancer	0.000358	0.000478	CcSEcCtD
Ribavirin—Oedema peripheral—Epirubicin—thyroid cancer	0.000357	0.000476	CcSEcCtD
Ribavirin—Connective tissue disorder—Epirubicin—thyroid cancer	0.000356	0.000475	CcSEcCtD
Ribavirin—Urethral disorder—Epirubicin—thyroid cancer	0.000355	0.000474	CcSEcCtD
Ribavirin—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.000353	0.000471	CcSEcCtD
Ribavirin—Epistaxis—Doxorubicin—thyroid cancer	0.000353	0.00047	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—PTEN—thyroid cancer	0.000351	0.0135	CbGpPWpGaD
Ribavirin—Sinusitis—Doxorubicin—thyroid cancer	0.000351	0.000468	CcSEcCtD
Ribavirin—Visual impairment—Epirubicin—thyroid cancer	0.000349	0.000466	CcSEcCtD
Ribavirin—Erythema multiforme—Epirubicin—thyroid cancer	0.000343	0.000457	CcSEcCtD
Ribavirin—Bradycardia—Doxorubicin—thyroid cancer	0.000342	0.000456	CcSEcCtD
Ribavirin—ADK—Metabolism—CHST14—thyroid cancer	0.000341	0.0131	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TCF7L1—thyroid cancer	0.000339	0.0131	CbGpPWpGaD
Ribavirin—Eye disorder—Epirubicin—thyroid cancer	0.000339	0.000452	CcSEcCtD
Ribavirin—Tinnitus—Epirubicin—thyroid cancer	0.000338	0.000451	CcSEcCtD
Ribavirin—Haemoglobin—Doxorubicin—thyroid cancer	0.000337	0.00045	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000337	0.013	CbGpPWpGaD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—CP—thyroid cancer	0.000337	0.013	CbGpPWpGaD
Ribavirin—Cardiac disorder—Epirubicin—thyroid cancer	0.000337	0.000449	CcSEcCtD
Ribavirin—Flushing—Epirubicin—thyroid cancer	0.000337	0.000449	CcSEcCtD
Ribavirin—Rhinitis—Doxorubicin—thyroid cancer	0.000336	0.000449	CcSEcCtD
Ribavirin—Haemorrhage—Doxorubicin—thyroid cancer	0.000336	0.000447	CcSEcCtD
Ribavirin—Hepatitis—Doxorubicin—thyroid cancer	0.000336	0.000447	CcSEcCtD
Ribavirin—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000334	0.000445	CcSEcCtD
Ribavirin—Pharyngitis—Doxorubicin—thyroid cancer	0.000333	0.000444	CcSEcCtD
Ribavirin—Urinary tract disorder—Doxorubicin—thyroid cancer	0.000331	0.000442	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000331	0.0128	CbGpPWpGaD
Ribavirin—Oedema peripheral—Doxorubicin—thyroid cancer	0.000331	0.000441	CcSEcCtD
Ribavirin—Connective tissue disorder—Doxorubicin—thyroid cancer	0.00033	0.00044	CcSEcCtD
Ribavirin—Angiopathy—Epirubicin—thyroid cancer	0.000329	0.000439	CcSEcCtD
Ribavirin—Urethral disorder—Doxorubicin—thyroid cancer	0.000329	0.000439	CcSEcCtD
Ribavirin—Immune system disorder—Epirubicin—thyroid cancer	0.000328	0.000437	CcSEcCtD
Ribavirin—Mediastinal disorder—Epirubicin—thyroid cancer	0.000327	0.000436	CcSEcCtD
Ribavirin—Chills—Epirubicin—thyroid cancer	0.000325	0.000434	CcSEcCtD
Ribavirin—Arrhythmia—Epirubicin—thyroid cancer	0.000324	0.000432	CcSEcCtD
Ribavirin—Visual impairment—Doxorubicin—thyroid cancer	0.000323	0.000431	CcSEcCtD
Ribavirin—Alopecia—Epirubicin—thyroid cancer	0.00032	0.000427	CcSEcCtD
Ribavirin—Mental disorder—Epirubicin—thyroid cancer	0.000318	0.000424	CcSEcCtD
Ribavirin—Erythema multiforme—Doxorubicin—thyroid cancer	0.000317	0.000423	CcSEcCtD
Ribavirin—Erythema—Epirubicin—thyroid cancer	0.000316	0.000421	CcSEcCtD
Ribavirin—Malnutrition—Epirubicin—thyroid cancer	0.000316	0.000421	CcSEcCtD
Ribavirin—Eye disorder—Doxorubicin—thyroid cancer	0.000314	0.000418	CcSEcCtD
Ribavirin—Tinnitus—Doxorubicin—thyroid cancer	0.000313	0.000417	CcSEcCtD
Ribavirin—Cardiac disorder—Doxorubicin—thyroid cancer	0.000311	0.000415	CcSEcCtD
Ribavirin—Flushing—Doxorubicin—thyroid cancer	0.000311	0.000415	CcSEcCtD
Ribavirin—Flatulence—Epirubicin—thyroid cancer	0.000311	0.000415	CcSEcCtD
Ribavirin—Tension—Epirubicin—thyroid cancer	0.00031	0.000413	CcSEcCtD
Ribavirin—Dysgeusia—Epirubicin—thyroid cancer	0.000309	0.000412	CcSEcCtD
Ribavirin—Nervousness—Epirubicin—thyroid cancer	0.000307	0.000409	CcSEcCtD
Ribavirin—Back pain—Epirubicin—thyroid cancer	0.000305	0.000407	CcSEcCtD
Ribavirin—Angiopathy—Doxorubicin—thyroid cancer	0.000304	0.000406	CcSEcCtD
Ribavirin—Muscle spasms—Epirubicin—thyroid cancer	0.000303	0.000405	CcSEcCtD
Ribavirin—Immune system disorder—Doxorubicin—thyroid cancer	0.000303	0.000404	CcSEcCtD
Ribavirin—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000302	0.000403	CcSEcCtD
Ribavirin—Chills—Doxorubicin—thyroid cancer	0.000301	0.000401	CcSEcCtD
Ribavirin—Arrhythmia—Doxorubicin—thyroid cancer	0.0003	0.0004	CcSEcCtD
Ribavirin—Vision blurred—Epirubicin—thyroid cancer	0.000298	0.000397	CcSEcCtD
Ribavirin—Alopecia—Doxorubicin—thyroid cancer	0.000296	0.000395	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—HPGD—thyroid cancer	0.000295	0.0114	CbGpPWpGaD
Ribavirin—Mental disorder—Doxorubicin—thyroid cancer	0.000294	0.000392	CcSEcCtD
Ribavirin—Ill-defined disorder—Epirubicin—thyroid cancer	0.000293	0.000391	CcSEcCtD
Ribavirin—Malnutrition—Doxorubicin—thyroid cancer	0.000292	0.00039	CcSEcCtD
Ribavirin—Erythema—Doxorubicin—thyroid cancer	0.000292	0.00039	CcSEcCtD
Ribavirin—Anaemia—Epirubicin—thyroid cancer	0.000292	0.000389	CcSEcCtD
Ribavirin—Agitation—Epirubicin—thyroid cancer	0.00029	0.000387	CcSEcCtD
Ribavirin—Flatulence—Doxorubicin—thyroid cancer	0.000288	0.000384	CcSEcCtD
Ribavirin—Tension—Doxorubicin—thyroid cancer	0.000287	0.000382	CcSEcCtD
Ribavirin—Dysgeusia—Doxorubicin—thyroid cancer	0.000286	0.000381	CcSEcCtD
Ribavirin—Malaise—Epirubicin—thyroid cancer	0.000285	0.00038	CcSEcCtD
Ribavirin—Nervousness—Doxorubicin—thyroid cancer	0.000284	0.000378	CcSEcCtD
Ribavirin—Vertigo—Epirubicin—thyroid cancer	0.000284	0.000378	CcSEcCtD
Ribavirin—Syncope—Epirubicin—thyroid cancer	0.000283	0.000378	CcSEcCtD
Ribavirin—Leukopenia—Epirubicin—thyroid cancer	0.000283	0.000377	CcSEcCtD
Ribavirin—Back pain—Doxorubicin—thyroid cancer	0.000283	0.000377	CcSEcCtD
Ribavirin—Muscle spasms—Doxorubicin—thyroid cancer	0.000281	0.000374	CcSEcCtD
Ribavirin—Palpitations—Epirubicin—thyroid cancer	0.000279	0.000372	CcSEcCtD
Ribavirin—Loss of consciousness—Epirubicin—thyroid cancer	0.000277	0.00037	CcSEcCtD
Ribavirin—Cough—Epirubicin—thyroid cancer	0.000275	0.000367	CcSEcCtD
Ribavirin—Vision blurred—Doxorubicin—thyroid cancer	0.000275	0.000367	CcSEcCtD
Ribavirin—ADK—Metabolism—HPGD—thyroid cancer	0.000274	0.0106	CbGpPWpGaD
Ribavirin—Convulsion—Epirubicin—thyroid cancer	0.000274	0.000365	CcSEcCtD
Ribavirin—Hypertension—Epirubicin—thyroid cancer	0.000273	0.000363	CcSEcCtD
Ribavirin—Ill-defined disorder—Doxorubicin—thyroid cancer	0.000271	0.000361	CcSEcCtD
Ribavirin—Anaemia—Doxorubicin—thyroid cancer	0.00027	0.00036	CcSEcCtD
Ribavirin—Chest pain—Epirubicin—thyroid cancer	0.000269	0.000358	CcSEcCtD
Ribavirin—Arthralgia—Epirubicin—thyroid cancer	0.000269	0.000358	CcSEcCtD
Ribavirin—Myalgia—Epirubicin—thyroid cancer	0.000269	0.000358	CcSEcCtD
Ribavirin—Agitation—Doxorubicin—thyroid cancer	0.000268	0.000358	CcSEcCtD
Ribavirin—Anxiety—Epirubicin—thyroid cancer	0.000268	0.000357	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000267	0.000356	CcSEcCtD
Ribavirin—Discomfort—Epirubicin—thyroid cancer	0.000266	0.000354	CcSEcCtD
Ribavirin—Malaise—Doxorubicin—thyroid cancer	0.000263	0.000351	CcSEcCtD
Ribavirin—Dry mouth—Epirubicin—thyroid cancer	0.000263	0.000351	CcSEcCtD
Ribavirin—Vertigo—Doxorubicin—thyroid cancer	0.000262	0.00035	CcSEcCtD
Ribavirin—Syncope—Doxorubicin—thyroid cancer	0.000262	0.000349	CcSEcCtD
Ribavirin—Leukopenia—Doxorubicin—thyroid cancer	0.000261	0.000349	CcSEcCtD
Ribavirin—Confusional state—Epirubicin—thyroid cancer	0.00026	0.000346	CcSEcCtD
Ribavirin—Palpitations—Doxorubicin—thyroid cancer	0.000258	0.000344	CcSEcCtD
Ribavirin—Anaphylactic shock—Epirubicin—thyroid cancer	0.000258	0.000344	CcSEcCtD
Ribavirin—Oedema—Epirubicin—thyroid cancer	0.000258	0.000344	CcSEcCtD
Ribavirin—Loss of consciousness—Doxorubicin—thyroid cancer	0.000257	0.000342	CcSEcCtD
Ribavirin—Cough—Doxorubicin—thyroid cancer	0.000255	0.00034	CcSEcCtD
Ribavirin—Shock—Epirubicin—thyroid cancer	0.000253	0.000338	CcSEcCtD
Ribavirin—Convulsion—Doxorubicin—thyroid cancer	0.000253	0.000337	CcSEcCtD
Ribavirin—Nervous system disorder—Epirubicin—thyroid cancer	0.000253	0.000337	CcSEcCtD
Ribavirin—Thrombocytopenia—Epirubicin—thyroid cancer	0.000252	0.000336	CcSEcCtD
Ribavirin—Hypertension—Doxorubicin—thyroid cancer	0.000252	0.000336	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000252	0.0097	CbGpPWpGaD
Ribavirin—Tachycardia—Epirubicin—thyroid cancer	0.000251	0.000335	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000251	0.00966	CbGpPWpGaD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000251	0.00966	CbGpPWpGaD
Ribavirin—Skin disorder—Epirubicin—thyroid cancer	0.00025	0.000334	CcSEcCtD
Ribavirin—Hyperhidrosis—Epirubicin—thyroid cancer	0.000249	0.000332	CcSEcCtD
Ribavirin—Chest pain—Doxorubicin—thyroid cancer	0.000249	0.000332	CcSEcCtD
Ribavirin—Arthralgia—Doxorubicin—thyroid cancer	0.000249	0.000332	CcSEcCtD
Ribavirin—Myalgia—Doxorubicin—thyroid cancer	0.000249	0.000332	CcSEcCtD
Ribavirin—ENPP1—Disease—TPR—thyroid cancer	0.000248	0.00957	CbGpPWpGaD
Ribavirin—Anxiety—Doxorubicin—thyroid cancer	0.000248	0.00033	CcSEcCtD
Ribavirin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000247	0.000329	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000247	0.00951	CbGpPWpGaD
Ribavirin—Discomfort—Doxorubicin—thyroid cancer	0.000246	0.000328	CcSEcCtD
Ribavirin—Anorexia—Epirubicin—thyroid cancer	0.000246	0.000327	CcSEcCtD
Ribavirin—ENPP1—Disease—PRKAR1A—thyroid cancer	0.000244	0.00941	CbGpPWpGaD
Ribavirin—Dry mouth—Doxorubicin—thyroid cancer	0.000243	0.000324	CcSEcCtD
Ribavirin—Hypotension—Epirubicin—thyroid cancer	0.000241	0.000321	CcSEcCtD
Ribavirin—Confusional state—Doxorubicin—thyroid cancer	0.00024	0.000321	CcSEcCtD
Ribavirin—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000238	0.000318	CcSEcCtD
Ribavirin—Oedema—Doxorubicin—thyroid cancer	0.000238	0.000318	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000235	0.000313	CcSEcCtD
Ribavirin—Shock—Doxorubicin—thyroid cancer	0.000235	0.000313	CcSEcCtD
Ribavirin—Nervous system disorder—Doxorubicin—thyroid cancer	0.000234	0.000312	CcSEcCtD
Ribavirin—ENPP1—Disease—MEN1—thyroid cancer	0.000234	0.00899	CbGpPWpGaD
Ribavirin—Thrombocytopenia—Doxorubicin—thyroid cancer	0.000233	0.000311	CcSEcCtD
Ribavirin—Insomnia—Epirubicin—thyroid cancer	0.000233	0.000311	CcSEcCtD
Ribavirin—Tachycardia—Doxorubicin—thyroid cancer	0.000233	0.00031	CcSEcCtD
Ribavirin—Skin disorder—Doxorubicin—thyroid cancer	0.000232	0.000309	CcSEcCtD
Ribavirin—Paraesthesia—Epirubicin—thyroid cancer	0.000231	0.000308	CcSEcCtD
Ribavirin—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00023	0.000307	CcSEcCtD
Ribavirin—Dyspnoea—Epirubicin—thyroid cancer	0.00023	0.000306	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—HRAS—thyroid cancer	0.000229	0.00883	CbGpPWpGaD
Ribavirin—Somnolence—Epirubicin—thyroid cancer	0.000229	0.000305	CcSEcCtD
Ribavirin—Anorexia—Doxorubicin—thyroid cancer	0.000227	0.000303	CcSEcCtD
Ribavirin—Dyspepsia—Epirubicin—thyroid cancer	0.000227	0.000302	CcSEcCtD
Ribavirin—Decreased appetite—Epirubicin—thyroid cancer	0.000224	0.000299	CcSEcCtD
Ribavirin—Hypotension—Doxorubicin—thyroid cancer	0.000223	0.000297	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000222	0.000297	CcSEcCtD
Ribavirin—Fatigue—Epirubicin—thyroid cancer	0.000222	0.000296	CcSEcCtD
Ribavirin—Pain—Epirubicin—thyroid cancer	0.00022	0.000294	CcSEcCtD
Ribavirin—Constipation—Epirubicin—thyroid cancer	0.00022	0.000294	CcSEcCtD
Ribavirin—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000217	0.00029	CcSEcCtD
Ribavirin—Insomnia—Doxorubicin—thyroid cancer	0.000216	0.000288	CcSEcCtD
Ribavirin—Paraesthesia—Doxorubicin—thyroid cancer	0.000214	0.000285	CcSEcCtD
Ribavirin—Dyspnoea—Doxorubicin—thyroid cancer	0.000213	0.000283	CcSEcCtD
Ribavirin—Feeling abnormal—Epirubicin—thyroid cancer	0.000212	0.000283	CcSEcCtD
Ribavirin—Somnolence—Doxorubicin—thyroid cancer	0.000212	0.000283	CcSEcCtD
Ribavirin—SLC28A3—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000212	0.00815	CbGpPWpGaD
Ribavirin—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000211	0.000281	CcSEcCtD
Ribavirin—Dyspepsia—Doxorubicin—thyroid cancer	0.00021	0.00028	CcSEcCtD
Ribavirin—NT5C2—Metabolism—TPR—thyroid cancer	0.000208	0.00801	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—TPR—thyroid cancer	0.000208	0.00801	CbGpPWpGaD
Ribavirin—Decreased appetite—Doxorubicin—thyroid cancer	0.000207	0.000276	CcSEcCtD
Ribavirin—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000206	0.000274	CcSEcCtD
Ribavirin—Fatigue—Doxorubicin—thyroid cancer	0.000206	0.000274	CcSEcCtD
Ribavirin—Urticaria—Epirubicin—thyroid cancer	0.000205	0.000273	CcSEcCtD
Ribavirin—NT5C2—Metabolism—PRKAR1A—thyroid cancer	0.000205	0.00788	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PRKAR1A—thyroid cancer	0.000205	0.00788	CbGpPWpGaD
Ribavirin—Constipation—Doxorubicin—thyroid cancer	0.000204	0.000272	CcSEcCtD
Ribavirin—Pain—Doxorubicin—thyroid cancer	0.000204	0.000272	CcSEcCtD
Ribavirin—Abdominal pain—Epirubicin—thyroid cancer	0.000204	0.000272	CcSEcCtD
Ribavirin—Body temperature increased—Epirubicin—thyroid cancer	0.000204	0.000272	CcSEcCtD
Ribavirin—ENPP1—Insulin Signaling—AKT1—thyroid cancer	0.000202	0.00779	CbGpPWpGaD
Ribavirin—Feeling abnormal—Doxorubicin—thyroid cancer	0.000196	0.000262	CcSEcCtD
Ribavirin—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000195	0.00026	CcSEcCtD
Ribavirin—Hypersensitivity—Epirubicin—thyroid cancer	0.00019	0.000253	CcSEcCtD
Ribavirin—Urticaria—Doxorubicin—thyroid cancer	0.000189	0.000253	CcSEcCtD
Ribavirin—Abdominal pain—Doxorubicin—thyroid cancer	0.000188	0.000251	CcSEcCtD
Ribavirin—Body temperature increased—Doxorubicin—thyroid cancer	0.000188	0.000251	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000188	0.00723	CbGpPWpGaD
Ribavirin—ENPP1—Disease—CALCA—thyroid cancer	0.000186	0.00716	CbGpPWpGaD
Ribavirin—Asthenia—Epirubicin—thyroid cancer	0.000185	0.000246	CcSEcCtD
Ribavirin—Pruritus—Epirubicin—thyroid cancer	0.000182	0.000243	CcSEcCtD
Ribavirin—Diarrhoea—Epirubicin—thyroid cancer	0.000176	0.000235	CcSEcCtD
Ribavirin—Hypersensitivity—Doxorubicin—thyroid cancer	0.000176	0.000234	CcSEcCtD
Ribavirin—Asthenia—Doxorubicin—thyroid cancer	0.000171	0.000228	CcSEcCtD
Ribavirin—Dizziness—Epirubicin—thyroid cancer	0.00017	0.000227	CcSEcCtD
Ribavirin—IMPDH1—Metabolism—TPR—thyroid cancer	0.00017	0.00653	CbGpPWpGaD
Ribavirin—Pruritus—Doxorubicin—thyroid cancer	0.000169	0.000225	CcSEcCtD
Ribavirin—ENPP1—Disease—CDK1—thyroid cancer	0.000168	0.00648	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PRKAR1A—thyroid cancer	0.000167	0.00642	CbGpPWpGaD
Ribavirin—Vomiting—Epirubicin—thyroid cancer	0.000164	0.000218	CcSEcCtD
Ribavirin—Diarrhoea—Doxorubicin—thyroid cancer	0.000163	0.000218	CcSEcCtD
Ribavirin—Rash—Epirubicin—thyroid cancer	0.000162	0.000217	CcSEcCtD
Ribavirin—Dermatitis—Epirubicin—thyroid cancer	0.000162	0.000216	CcSEcCtD
Ribavirin—Headache—Epirubicin—thyroid cancer	0.000161	0.000215	CcSEcCtD
Ribavirin—SLC29A1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000158	0.00608	CbGpPWpGaD
Ribavirin—ADK—Metabolism—TPR—thyroid cancer	0.000158	0.00607	CbGpPWpGaD
Ribavirin—Dizziness—Doxorubicin—thyroid cancer	0.000158	0.00021	CcSEcCtD
Ribavirin—NT5C2—Metabolism—SLC5A5—thyroid cancer	0.000156	0.006	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—SLC5A5—thyroid cancer	0.000156	0.006	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PRKAR1A—thyroid cancer	0.000155	0.00597	CbGpPWpGaD
Ribavirin—Nausea—Epirubicin—thyroid cancer	0.000153	0.000204	CcSEcCtD
Ribavirin—Vomiting—Doxorubicin—thyroid cancer	0.000152	0.000202	CcSEcCtD
Ribavirin—Rash—Doxorubicin—thyroid cancer	0.00015	0.0002	CcSEcCtD
Ribavirin—Dermatitis—Doxorubicin—thyroid cancer	0.00015	0.0002	CcSEcCtD
Ribavirin—Headache—Doxorubicin—thyroid cancer	0.000149	0.000199	CcSEcCtD
Ribavirin—Nausea—Doxorubicin—thyroid cancer	0.000142	0.000189	CcSEcCtD
Ribavirin—ENPP1—Disease—NRG1—thyroid cancer	0.000135	0.0052	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—RXRA—thyroid cancer	0.000131	0.00504	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—RXRA—thyroid cancer	0.000131	0.00504	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—SLC5A5—thyroid cancer	0.000127	0.00489	CbGpPWpGaD
Ribavirin—ENPP1—Disease—TERT—thyroid cancer	0.000121	0.00467	CbGpPWpGaD
Ribavirin—ADK—Metabolism—SLC5A5—thyroid cancer	0.000118	0.00454	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HIF1A—thyroid cancer	0.000116	0.00447	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—RXRA—thyroid cancer	0.000107	0.00411	CbGpPWpGaD
Ribavirin—ADK—Metabolism—RXRA—thyroid cancer	9.92e-05	0.00382	CbGpPWpGaD
Ribavirin—ENPP1—Disease—BRAF—thyroid cancer	9.61e-05	0.0037	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PPARG—thyroid cancer	8.26e-05	0.00318	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PPARG—thyroid cancer	8.26e-05	0.00318	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTGS2—thyroid cancer	7.76e-05	0.00299	CbGpPWpGaD
Ribavirin—ENPP1—Disease—PTEN—thyroid cancer	6.77e-05	0.00261	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PPARG—thyroid cancer	6.73e-05	0.00259	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTGS2—thyroid cancer	6.5e-05	0.0025	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTGS2—thyroid cancer	6.5e-05	0.0025	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PPARG—thyroid cancer	6.26e-05	0.00241	CbGpPWpGaD
Ribavirin—ENPP1—Disease—NRAS—thyroid cancer	6.04e-05	0.00233	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—PTEN—thyroid cancer	5.67e-05	0.00218	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—PTEN—thyroid cancer	5.67e-05	0.00218	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTGS2—thyroid cancer	5.3e-05	0.00204	CbGpPWpGaD
Ribavirin—ENPP1—Disease—KRAS—thyroid cancer	5.2e-05	0.002	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTGS2—thyroid cancer	4.93e-05	0.0019	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—PTEN—thyroid cancer	4.62e-05	0.00178	CbGpPWpGaD
Ribavirin—ENPP1—Disease—HRAS—thyroid cancer	4.42e-05	0.0017	CbGpPWpGaD
Ribavirin—ADK—Metabolism—PTEN—thyroid cancer	4.3e-05	0.00165	CbGpPWpGaD
Ribavirin—ENPP1—Disease—AKT1—thyroid cancer	3.9e-05	0.0015	CbGpPWpGaD
Ribavirin—NT5C2—Metabolism—AKT1—thyroid cancer	3.27e-05	0.00126	CbGpPWpGaD
Ribavirin—ENPP1—Metabolism—AKT1—thyroid cancer	3.27e-05	0.00126	CbGpPWpGaD
Ribavirin—IMPDH1—Metabolism—AKT1—thyroid cancer	2.66e-05	0.00103	CbGpPWpGaD
Ribavirin—ADK—Metabolism—AKT1—thyroid cancer	2.48e-05	0.000953	CbGpPWpGaD
